TNFRSF14 and graft versus host disease: Interestingly, in a GVHD model, expression of a truncated form of BTLA lacking the intracellular signaling domain was sufficient to prolong the survival of the chronically stimulated Btla−/− donor T cells, suggesting that BTLA promotes T cell survival acting principally as a ligand for HVEM [15].